Daftar Isi
1. FDA approves Teva's generic EpiPen
CNBC's Meg Tirrell reports on U.S. regulators clearing the first generic competitor to Mylan's EpiPen, after a yearslong delay that ...
2. Teva Pharmaceuticals CEO on earnings beat: Our shift to biopharma is working
Richard Francis,
3. Forty-four states accuse Teva Pharmaceutical of inflating drug prices
Forty-four U.S. states, led by Connecticut Attorney General William Tong, claim that 20 drug companies, including
4. Teva recalls over 500,000 bottles of blood pressure drug
5. Teva Pharmaceuticals Facts and Figures
We are all in for better health.
6. Teva Hits Highest Since 2018 as 3Q Revenue Beats Estimates
7. 480 million doses of medicine: Go behind the Scenes at Teva's UK plant
Join Hikky, Paul and Amy as they take us behind the scenes and show us some of the quality and safety checks that goes in to ...
8. Teva Pharma CEO Richard Francis on Q4 earnings
Richard Francis,
9. Municipalities not on board with Teva settlement
CNBC's Meg Tirrell reports conflicting viewpoints coming out of the
10. Teva is most at risk in the opioid trials, says Vanity Fair's McLean
Opening statements began Monday in the nation's first federal trial over the opioid crisis. Beth McLean, Vanity Fair contributing ...
11. Medial Devices & Teva. Plus, the bullish bet on this food stock
Bernstein initiates coverage on health care names, with Intuitive Surgical, Boston Scientific, and Abbott Labs getting outperform ...
12. Teva considers sale of its active ingredients unit: Bloomberg
13. Teva in Talks to Help Make Covid Vaccines, CEO Says
Feb.10 --
14. Teva, Others in Talks With DOJ to End Generic Drug Probe
Nov.25 --
15. DOJ orders Teva and Glenmark to pay millions in fines in drug price fixing settlment
CNBC's Bertha Coombs joins 'Closing Bell Overtime' with breaking news on the DOJ's antitrust agreement involving
5728 Teva Information Guide
About on 5728 Teva
Important Facts
Latest News
Detailed Analysis
Data is compiled from public records and verified media reports.
Last Updated: August 10, 2026
Summary
Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.